{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T15:57:49Z","timestamp":1785772669221,"version":"3.56.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T00:00:00Z","timestamp":1725840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T00:00:00Z","timestamp":1725840000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"NIH\/NCI","award":["P30 CA008748"],"award-info":[{"award-number":["P30 CA008748"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pituitary"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1007\/s11102-024-01450-8","type":"journal-article","created":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T16:02:36Z","timestamp":1725897756000},"page":"654-664","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Sleep disruption in patients with active and treated endogenous Cushing\u2019s syndrome"],"prefix":"10.1007","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3722-1889","authenticated-orcid":false,"given":"Eliza B.","family":"Geer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Grillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Robins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Baratz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Sazo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viviane","family":"Tabar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheila N.","family":"Garland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,9]]},"reference":[{"key":"1450_CR1","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/S0140-6736(14)61375-1","volume":"386","author":"A Lacroix","year":"2015","unstructured":"Lacroix A, Feelders RA, Stratakis CA, Nieman LK (2015) Cushing\u2019s syndrome. Lancet 386:913\u2013927","journal-title":"Lancet"},{"key":"1450_CR2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/00006842-198102000-00002","volume":"43","author":"MN Starkman","year":"1981","unstructured":"Starkman MN, Schteingart DE, Schork MA (1981) Depressed mood and other psychiatric manifestations of Cushing\u2019s syndrome: relationship to hormone levels. Psychosom Med 43:3\u201318","journal-title":"Psychosom Med"},{"key":"1450_CR3","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1530\/EJE-11-1095","volume":"167","author":"RA Feelders","year":"2012","unstructured":"Feelders RA, Pulgar SJ, Kempel A, Pereira AM (2012) The burden of Cushing\u2019s disease: clinical and health-related quality of life aspects. Eur J Endocrinol 167:311\u2013326","journal-title":"Eur J Endocrinol"},{"key":"1450_CR4","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1210\/jc.2011-3123","volume":"97","author":"EB Geer","year":"2012","unstructured":"Geer EB, Shen W, Strohmayer E et al (2012) Body composition and cardiovascular risk markers after remission of Cushing\u2019s disease: a prospective study using whole-body MRI. J Clin Endocrinol Metab 97:1702\u20131711","journal-title":"J Clin Endocrinol Metab"},{"key":"1450_CR5","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1111\/j.1365-2265.2010.03829.x","volume":"73","author":"EB Geer","year":"2010","unstructured":"Geer EB, Shen W, Gallagher D et al (2010) MRI assessment of lean and adipose tissue distribution in female patients with Cushing\u2019s disease. Clin Endocrinol 73:469\u2013475","journal-title":"Clin Endocrinol"},{"key":"1450_CR6","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1111\/cen.13230","volume":"86","author":"N Shah","year":"2017","unstructured":"Shah N, Ruiz HH, Zafar U et al (2017) Proinflammatory cytokines remain elevated despite long-term remission in Cushing\u2019s disease: a prospective study. Clin Endocrinol 86:68\u201374","journal-title":"Clin Endocrinol"},{"key":"1450_CR7","doi-asserted-by":"publisher","first-page":"2807","DOI":"10.1210\/jc.2015-1818","volume":"100","author":"LK Nieman","year":"2015","unstructured":"Nieman LK, Biller BM, Findling JW et al (2015) Treatment of Cushing\u2019s syndrome: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 100:2807\u20132831","journal-title":"J Clin Endocrinol Metab"},{"key":"1450_CR8","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1159\/000318505","volume":"38","author":"MJ Barahona","year":"2010","unstructured":"Barahona MJ, Resmini E, Sucunza N, Webb SM (2010) Diagnosis of cure in Cushing\u2019s syndrome: lessons from long-term follow-up. Front Horm Res 38:152\u2013157","journal-title":"Front Horm Res"},{"key":"1450_CR9","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1111\/j.1365-2265.2004.02118.x","volume":"61","author":"AH Heald","year":"2004","unstructured":"Heald AH, Ghosh S, Bray S et al (2004) Long-term negative impact on quality of life in patients with successfully treated Cushing\u2019s disease. Clin Endocrinol (Oxf) 61:458\u2013465","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1450_CR10","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s11154-009-9123-7","volume":"11","author":"N Sonino","year":"2010","unstructured":"Sonino N, Fallo F, Fava GA (2010) Psychosomatic aspects of Cushing\u2019s syndrome. Reviews Endocr Metabolic Disorders 11:95\u2013104","journal-title":"Reviews Endocr Metabolic Disorders"},{"issue":"Suppl 1","key":"1450_CR11","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1159\/000314317","volume":"92","author":"AM Pereira","year":"2010","unstructured":"Pereira AM, Tiemensma J, Romijn JA (2010) Neuropsychiatric disorders in Cushing\u2019s syndrome. Neuroendocrinology 92(Suppl 1):65\u201370","journal-title":"Neuroendocrinology"},{"key":"1450_CR12","doi-asserted-by":"publisher","first-page":"E129","DOI":"10.1210\/jc.2010-0512","volume":"95","author":"J Tiemensma","year":"2010","unstructured":"Tiemensma J, Biermasz NR, Middelkoop HA et al (2010) Increased prevalence of psychopathology and maladaptive personality traits after long-term cure of Cushing\u2019s disease. J Clin Endocrinol Metab 95:E129\u2013E141","journal-title":"J Clin Endocrinol Metab"},{"key":"1450_CR13","first-page":"5325","volume":"104","author":"LHA Broersen","year":"2019","unstructured":"Broersen LHA, Andela CD, Dekkers OM et al (2019) Improvement but no normalization of quality of life and cognitive functioning after treatment of Cushing Syndrome. J Clin Endocrinol Metab 104:5325\u20135337","journal-title":"J Clin Endocrinol Metab"},{"key":"1450_CR14","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1210\/jc.2008-0125","volume":"93","author":"LK Nieman","year":"2008","unstructured":"Nieman LK, Biller BM, Findling JW et al (2008) The diagnosis of Cushing\u2019s syndrome: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 93:1526\u20131540","journal-title":"J Clin Endocrinol Metab"},{"key":"1450_CR15","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1038\/nrendo.2009.106","volume":"5","author":"GP Chrousos","year":"2009","unstructured":"Chrousos GP (2009) Stress and disorders of the stress system. Nat Rev Endocrinol 5:374\u2013381","journal-title":"Nat Rev Endocrinol"},{"key":"1450_CR16","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1093\/sleep\/15.6.514","volume":"15","author":"JE Shipley","year":"1992","unstructured":"Shipley JE, Schteingart DE, Tandon R, Starkman MN (1992) Sleep architecture and sleep apnea in patients with Cushing\u2019s disease. Sleep 15:514\u2013518","journal-title":"Sleep"},{"key":"1450_CR17","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1210\/jcem-39-6-986","volume":"39","author":"DT Krieger","year":"1974","unstructured":"Krieger DT, Glick SM (1974) Sleep EEG stages and plasma growth hormone concentration in states of endogenous and exogenous hypercortisolemia or ACTH elevation. J Clin Endocrinol Metab 39:986\u20131000","journal-title":"J Clin Endocrinol Metab"},{"key":"1450_CR18","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1007\/s11102-015-0667-0","volume":"18","author":"V D\u2019Angelo","year":"2015","unstructured":"D\u2019Angelo V, Beccuti G, Berardelli R et al (2015) Cushing\u2019s syndrome is associated with sleep alterations detected by wrist actigraphy. Pituitary 18:893\u2013897","journal-title":"Pituitary"},{"key":"1450_CR19","first-page":"912","volume":"82","author":"LD Dorn","year":"1997","unstructured":"Dorn LD, Burgess ES, Friedman TC et al (1997) The longitudinal course of psychopathology in Cushing\u2019s syndrome after correction of hypercortisolism. J Clin Endocrinol Metab 82:912\u2013919","journal-title":"J Clin Endocrinol Metab"},{"key":"1450_CR20","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1210\/jc.2005-1058","volume":"91","author":"JR Lindsay","year":"2006","unstructured":"Lindsay JR, Nansel T, Baid S et al (2006) Long-term impaired quality of life in Cushing\u2019s syndrome despite initial improvement after surgical remission. J Clin Endocrinol Metab 91:447\u2013453","journal-title":"J Clin Endocrinol Metab"},{"key":"1450_CR21","doi-asserted-by":"publisher","first-page":"3279","DOI":"10.1210\/jc.2004-1375","volume":"90","author":"MO van Aken","year":"2005","unstructured":"van Aken MO, Pereira AM, Biermasz NR et al (2005) Quality of life in patients after long-term biochemical cure of Cushing\u2019s disease. J Clin Endocrinol Metab 90:3279\u20133286","journal-title":"J Clin Endocrinol Metab"},{"key":"1450_CR22","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1111\/cen.12521","volume":"82","author":"A Carluccio","year":"2015","unstructured":"Carluccio A, Sundaram NK, Chablani S et al (2015) Predictors of quality of life in 102 patients with treated Cushing\u2019s disease. Clin Endocrinol 82:404\u2013411","journal-title":"Clin Endocrinol"},{"key":"1450_CR23","doi-asserted-by":"publisher","first-page":"3365","DOI":"10.1210\/jc.2009-0766","volume":"94","author":"MJ Barahona","year":"2009","unstructured":"Barahona MJ, Sucunza N, Resmini E et al (2009) Persistent body fat mass and inflammatory marker increases after long-term cure of Cushing\u2019s syndrome. J Clin Endocrinol Metab 94:3365\u20133371","journal-title":"J Clin Endocrinol Metab"},{"key":"1450_CR24","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1210\/jc.2006-2112","volume":"92","author":"OM Dekkers","year":"2007","unstructured":"Dekkers OM, Biermasz NR, Pereira AM et al (2007) Mortality in patients treated for Cushing\u2019s disease is increased, compared with patients treated for nonfunctioning pituitary macroadenoma. J Clin Endocrinol Metab 92:976\u2013981","journal-title":"J Clin Endocrinol Metab"},{"key":"1450_CR25","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1210\/jc.2010-1942","volume":"96","author":"RN Clayton","year":"2011","unstructured":"Clayton RN, Raskauskiene D, Reulen RC, Jones PW (2011) Mortality and morbidity in Cushing\u2019s disease over 50 years in stoke-on-trent, UK: audit and meta-analysis of literature. J Clin Endocrinol Metab 96:632\u2013642","journal-title":"J Clin Endocrinol Metab"},{"key":"1450_CR26","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1210\/jc.2011-2957","volume":"97","author":"ZK Hassan-Smith","year":"2012","unstructured":"Hassan-Smith ZK, Sherlock M, Reulen RC et al (2012) Outcome of Cushing\u2019s disease following transsphenoidal surgery in a single center over 20 years. J Clin Endocrinol Metab 97:1194\u20131201","journal-title":"J Clin Endocrinol Metab"},{"key":"1450_CR27","doi-asserted-by":"publisher","first-page":"2454","DOI":"10.1210\/jc.2007-2734","volume":"93","author":"BM Biller","year":"2008","unstructured":"Biller BM, Grossman AB, Stewart PM et al (2008) Treatment of adrenocorticotropin-dependent Cushing\u2019s syndrome: a consensus statement. J Clin Endocrinol Metab 93:2454\u20132462","journal-title":"J Clin Endocrinol Metab"},{"key":"1450_CR28","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/S2213-8587(21)00235-7","volume":"9","author":"M Fleseriu","year":"2021","unstructured":"Fleseriu M, Auchus R, Bancos I et al (2021) Consensus on diagnosis and management of Cushing\u2019s disease: a guideline update. Lancet Diabetes Endocrinol 9:847\u2013875","journal-title":"Lancet Diabetes Endocrinol"},{"key":"1450_CR29","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1136\/jech.34.4.281","volume":"34","author":"SM Hunt","year":"1980","unstructured":"Hunt SM, McKenna SP, McEwen J et al (1980) A quantitative approach to perceived health status: a validation study. J Epidemiol Community Health 34:281\u2013286","journal-title":"J Epidemiol Community Health"},{"key":"1450_CR30","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1530\/EJE-07-0762","volume":"158","author":"SM Webb","year":"2008","unstructured":"Webb SM, Badia X, Barahona MJ et al (2008) Evaluation of health-related quality of life in patients with Cushing\u2019s syndrome with a new questionnaire. Eur J Endocrinol 158:623\u2013630","journal-title":"Eur J Endocrinol"},{"key":"1450_CR31","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","volume":"67","author":"AS Zigmond","year":"1983","unstructured":"Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67:361\u2013370","journal-title":"Acta Psychiatr Scand"},{"key":"1450_CR32","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1192\/bjp.179.6.540","volume":"179","author":"A Mykletun","year":"2001","unstructured":"Mykletun A, Stordal E, Dahl AA (2001) Hospital anxiety and depression (HAD) scale: factor structure, item analyses and internal consistency in a large population. Br J Psychiatry 179:540\u2013544","journal-title":"Br J Psychiatry"},{"key":"1450_CR33","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s00520-012-1490-z","volume":"21","author":"K Desai","year":"2013","unstructured":"Desai K, Mao JJ, Su I et al (2013) Prevalence and risk factors for insomnia among breast cancer patients on aromatase inhibitors. Support Care Cancer 21:43\u201351","journal-title":"Support Care Cancer"},{"key":"1450_CR34","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1007\/s11102-023-01314-7","volume":"26","author":"G Page-Wilson","year":"2023","unstructured":"Page-Wilson G, Oak B, Silber A et al (2023) Evaluating the burden of endogenous Cushing\u2019s syndrome using a web-based questionnaire and validated patient-reported outcome measures. Pituitary 26:364\u2013374","journal-title":"Pituitary"},{"key":"1450_CR35","doi-asserted-by":"publisher","first-page":"e2921","DOI":"10.1210\/clinem\/dgac174","volume":"107","author":"A Ebbehoj","year":"2022","unstructured":"Ebbehoj A, Sondergaard E, Jepsen P et al (2022) The socioeconomic consequences of Cushing\u2019s syndrome: a nationwide cohort study. J Clin Endocrinol Metab 107:e2921\u2013e2929","journal-title":"J Clin Endocrinol Metab"},{"key":"1450_CR36","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1007\/s11136-020-02480-y","volume":"29","author":"SA Moyers","year":"2020","unstructured":"Moyers SA, Tiemensma J (2020) The association between physical activity, sleep, and quality of life in patients in bio-chemical remission from Cushing\u2019s syndrome. Qual Life Res 29:2089\u20132100","journal-title":"Qual Life Res"},{"issue":"6","key":"1450_CR37","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1210\/clinem\/dgab079","volume":"106","author":"D Bengtsson","year":"2021","unstructured":"Bengtsson D, Ragnarsson O, Berinder K et al (2021) Psychotropic drugs in patients with Cushing\u2019s disease before diagnosis and at long-term follow-up - a nationwide study. J Clin Endocrinol Metab 106(6):1750\u20131760","journal-title":"J Clin Endocrinol Metab"},{"key":"1450_CR38","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.3390\/jcm12041629","volume":"12","author":"PC Zee","year":"2023","unstructured":"Zee PC, Bertisch SM, Morin CM et al (2023) Long-term use of insomnia medications: an appraisal of the current clinical and scientific evidence. J Clin Med 12:1629","journal-title":"J Clin Med"},{"key":"1450_CR39","first-page":"592","volume":"188","author":"CD Zhang","year":"2023","unstructured":"Zhang CD, Li D, Singh S et al (2023) Glucocorticoid withdrawal syndrome following surgical remission of endogenous hypercortisolism: a longitudinal observational study. Eur J Endocrinol 188:592\u2013602","journal-title":"Eur J Endocrinol"},{"key":"1450_CR40","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1007\/s11102-015-0692-z","volume":"19","author":"M Fleseriu","year":"2016","unstructured":"Fleseriu M, Pivonello R, Young J et al (2016) Osilodrostat, a potent oral 11beta-hydroxylase inhibitor: 22-week, prospective, phase II study in Cushing\u2019s disease. Pituitary 19:138\u2013148","journal-title":"Pituitary"}],"container-title":["Pituitary"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-024-01450-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11102-024-01450-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-024-01450-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T04:43:34Z","timestamp":1730781814000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11102-024-01450-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,9]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["1450"],"URL":"https:\/\/doi.org\/10.1007\/s11102-024-01450-8","relation":{},"ISSN":["1386-341X","1573-7403"],"issn-type":[{"value":"1386-341X","type":"print"},{"value":"1573-7403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,9]]},"assertion":[{"value":"22 August 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"EBG reports serving as an editor for <i>Pituitary<\/i> and is an investigator for research grants to MSKCC from Recordati, Sparrow, and Xeris, and serving as an occasional consultant to HRA Pharma, Sparrow, Xeris, and Lundbeck, none of which conflict with the current work. No other authors report a conflict.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}